• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清素转运体基因多态性(5-HTTLPR)与肠易激综合征:25项研究的荟萃分析

The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies.

作者信息

Zhang Zhi-Feng, Duan Zhi-Jun, Wang Li-Xia, Yang Dong, Zhao Gang, Zhang Lin

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Dalian Medical University, 116000 Dalian, Liaoning province, China.

出版信息

BMC Gastroenterol. 2014 Feb 10;14:23. doi: 10.1186/1471-230X-14-23.

DOI:10.1186/1471-230X-14-23
PMID:24512255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3926682/
Abstract

BACKGROUND

The results of previous studies assessing the association between the 5-HTTLPR polymorphism of serotonin transporter gene and irritable bowel syndrome (IBS) are inconsistent. The aim of this study was to clarify the association between the 5-HTTLPR mutation and the presence of IBS and its subtypes with a meta-analysis of 25 studies.

METHODS

A thorough search for case-control studies evaluating the association between the 5-HTTLPR polymorphism of serotonin transporter gene and the presence of IBS was carried out in four electronic databases. A meta-analysis was performed in accordance with the Cochrane Handbook for systemic reviews.

RESULTS

A total of 25 articles with 3443 IBS cases and 3359 controls were included into our meta-analysis. No significant association was found between this polymorphism and IBS in all populations. Whereas the LL genotype was demonstrated to be a risk factor for constipation predominant IBS (IBS-C) development in the overall population (LL vs SS: OR = 1.570, 95% CI = 1.147-2.148, P = 0.005, Bon = 0.030; LL vs LS: OR = 1.658, 95% CI = 1.180-2.331, P = 0.004, Bon = 0.024; LL vs LS/SS: OR = 1.545, 95% CI = 1.187-2.012, P = 0.001, Bon = 0.006). In the analysis of different ethnicities, L allele and LL genotype were significantly associated with increased IBS-C risk in the East Asian population (L vs S: OR = 1.487, 95% CI = 1.139-1.941, P = 0.003, Bon = 0.018; LL vs SS: OR = 2.575, 95% CI = 1.741-3.808, P = 0.000, Bon = 0.000; LL vs LS: OR = 3.084, 95% CI = 2.017-4.715, P = 0.000, Bon = 0.000; LL vs LS/SS: OR = 2.759, 95% CI = 1.933-3.938, P = 0.000, Bon = 0.000), but not in the Caucasian population.

CONCLUSIONS

Different from the conclusions of the earlier meta-analyses, the 5-HTTLPR mutation affects IBS-C but not IBS-D and IBS-M development and this effect only exists in the East Asian population but not other populations.

摘要

背景

先前评估血清素转运体基因5-HTTLPR多态性与肠易激综合征(IBS)之间关联的研究结果并不一致。本研究的目的是通过对25项研究进行荟萃分析,阐明5-HTTLPR突变与IBS及其亚型之间的关联。

方法

在四个电子数据库中全面检索评估血清素转运体基因5-HTTLPR多态性与IBS存在之间关联的病例对照研究。根据Cochrane系统评价手册进行荟萃分析。

结果

我们的荟萃分析共纳入25篇文章,其中包括3443例IBS病例和3359例对照。在所有人群中,该多态性与IBS之间未发现显著关联。然而,在总体人群中,LL基因型被证明是便秘型IBS(IBS-C)发生的危险因素(LL与SS比较:OR = 1.570,95%CI = 1.147 - 2.148,P = 0.005,Bon = 0.030;LL与LS比较:OR = 1.658,95%CI = 1.180 - 2.331,P = 0.004,Bon = 0.024;LL与LS/SS比较:OR = 1.545,95%CI = 1.187 - 2.012,P = 0.001,Bon = 0.006)。在不同种族分析中,L等位基因和LL基因型与东亚人群中IBS-C风险增加显著相关(L与S比较:OR = 1.487,95%CI = 1.139 - 1.941,P = 0.003,Bon = 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/1d31997d2886/1471-230X-14-23-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/12855eb7bebc/1471-230X-14-23-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/0bb0a1309206/1471-230X-14-23-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/d235b5fffda2/1471-230X-14-23-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/1d31997d2886/1471-230X-14-23-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/12855eb7bebc/1471-230X-14-23-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/0bb0a1309206/1471-230X-14-23-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/d235b5fffda2/1471-230X-14-23-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3181/3926682/1d31997d2886/1471-230X-14-23-4.jpg

相似文献

1
The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies.血清素转运体基因多态性(5-HTTLPR)与肠易激综合征:25项研究的荟萃分析
BMC Gastroenterol. 2014 Feb 10;14:23. doi: 10.1186/1471-230X-14-23.
2
5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex.5-羟色胺转运体基因中的 5-HTTLPR 和 STin2 多态性与肠易激综合征:肠习惯和性别的影响。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):856-61. doi: 10.1097/MEG.0b013e32832e9d6b.
3
A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis.血清素转运体基因(SLC6A4)多态性与美亚人群肠易激综合征发病风险降低相关:一项荟萃分析。
PLoS One. 2013 Sep 19;8(9):e75567. doi: 10.1371/journal.pone.0075567. eCollection 2013.
4
Association of serotonin transporter promoter polymorphism (5-HTTLPR) with orocecal transit time in irritable bowel syndrome.5-羟色胺转运体启动子多态性(5-HTTLPR)与肠易激综合征口盲肠传输时间的相关性
Indian J Gastroenterol. 2022 Dec;41(6):610-617. doi: 10.1007/s12664-022-01280-1. Epub 2022 Dec 27.
5
Meta-analysis of 5-hydroxytryptamine transporter gene promoter region polymorphism and post-stroke depression.5-羟色胺转运体基因启动子区多态性与卒中后抑郁的荟萃分析
J Int Med Res. 2020 Jun;48(6):300060520925943. doi: 10.1177/0300060520925943.
6
Association study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome.5-羟色胺转运体SLC6A4基因与中国汉族肠易激综合征的关联研究
PLoS One. 2014 Jan 2;9(1):e84414. doi: 10.1371/journal.pone.0084414. eCollection 2014.
7
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome.5-羟色胺转运体 5HTTLPR 多态性对肠易激综合征症状严重程度的影响。
PLoS One. 2013;8(2):e54831. doi: 10.1371/journal.pone.0054831. Epub 2013 Feb 5.
8
Serotonin transporter promoter variant: Analysis in Indian IBS patients and control population.5-羟色胺转运体启动子变异体:在印度 IBS 患者和对照人群中的分析。
J Clin Gastroenterol. 2009 Nov-Dec;43(10):957-61. doi: 10.1097/MCG.0b013e3181b37e8c.
9
[Correlation between curative effect and 5-HTTLPR polymorphism in treatment of diarrhea-predominant irritable bowel syndrome with acupuncture for regulating and strengthening spleen].针刺健脾法治疗腹泻型肠易激综合征疗效与5-HTTLPR基因多态性的相关性研究
Zhongguo Zhen Jiu. 2021 Apr 12;41(4):365-70. doi: 10.13703/j.0255-2930.20200313-k0002.
10
[Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment].[肠易激综合征中血清素转运体基因多态性及其对替加色罗治疗的影响]
Zhonghua Nei Ke Za Zhi. 2006 Jul;45(7):552-5.

引用本文的文献

1
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities.血清素(5-羟色胺):代谢、信号传导、生物学功能、疾病及新兴治疗机遇
MedComm (2020). 2025 Sep 9;6(9):e70383. doi: 10.1002/mco2.70383. eCollection 2025 Sep.
2
Risk factors for developing irritable bowel syndrome: systematic umbrella review of reviews.肠易激综合征的发病风险因素:系统性综述的综合评价
BMC Med. 2025 Feb 21;23(1):103. doi: 10.1186/s12916-025-03930-5.
3
Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism.

本文引用的文献

1
A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis.血清素转运体基因(SLC6A4)多态性与美亚人群肠易激综合征发病风险降低相关:一项荟萃分析。
PLoS One. 2013 Sep 19;8(9):e75567. doi: 10.1371/journal.pone.0075567. eCollection 2013.
2
Serotonin transporter gene polymorphisms in Southwestern Iranian patients with irritable bowel syndrome.伊朗西南部肠易激综合征患者的血清素转运体基因多态性
Arab J Gastroenterol. 2013 Jun;14(2):59-62. doi: 10.1016/j.ajg.2013.03.001. Epub 2013 Apr 6.
3
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.
肠易激综合征的药物遗传学:药物靶点和代谢的 GWAS 研究的最新进展和影响。
Expert Opin Drug Metab Toxicol. 2024 May;20(5):319-332. doi: 10.1080/17425255.2024.2349716. Epub 2024 May 26.
4
Update in diagnosis and management of irritable bowel syndrome.肠易激综合征诊断与管理的最新进展
Tzu Chi Med J. 2023 Sep 22;35(4):306-311. doi: 10.4103/tcmj.tcmj_104_23. eCollection 2023 Oct-Dec.
5
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.多组学在腹痛和肠易激综合征的诊断评估和管理中的生物标志物方法:未来的方向。
Gut Microbes. 2023 Jan-Dec;15(1):2195792. doi: 10.1080/19490976.2023.2195792.
6
Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.鉴定肠易激综合征(IBS)中的潜在转录组生物标志物:维生素 D 对 TPH1 和 SERT 的差异基因表达和调控。
PLoS One. 2022 Oct 20;17(10):e0275683. doi: 10.1371/journal.pone.0275683. eCollection 2022.
7
The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome.单核苷酸多态性与肠易激综合征风险及症状的关联
J Pers Med. 2022 Jan 21;12(2):142. doi: 10.3390/jpm12020142.
8
Impact of serotonin transporter gene polymorphism on gut motility in patients with type 2 Diabetes mellitus.血清素转运体基因多态性对2型糖尿病患者肠道蠕动的影响。
J Neurogastroenterol Motil. 2021 Apr 30;27(2):240-247. doi: 10.5056/jnm20211.
9
IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities.炎症性肠病患者的肠易激综合征症状——合并或不同实体的表现
J Clin Med. 2020 Dec 24;10(1):31. doi: 10.3390/jcm10010031.
10
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.国际基础和临床药理学联合会。CX. 5-羟色胺受体分类:药理学与功能。
Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.
S100A 表达和白细胞介素-10 多态性与溃疡性结肠炎和腹泻为主的肠易激综合征有关。
Dig Dis Sci. 2013 Aug;58(8):2314-23. doi: 10.1007/s10620-013-2677-y. Epub 2013 Apr 18.
4
Letter: serotonin transporter gene polymorphisms and the irritable bowel syndrome.信件:血清素转运体基因多态性与肠易激综合征
Aliment Pharmacol Ther. 2013 Mar;37(6):657-8. doi: 10.1111/apt.12222.
5
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome.5-羟色胺转运体 5HTTLPR 多态性对肠易激综合征症状严重程度的影响。
PLoS One. 2013;8(2):e54831. doi: 10.1371/journal.pone.0054831. Epub 2013 Feb 5.
6
The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS).5-HTT LPR 和 GNβ3 825C>T 多态性及基因-环境相互作用在肠易激综合征(IBS)中的作用。
Dig Dis Sci. 2012 Oct;57(10):2650-7. doi: 10.1007/s10620-012-2319-9. Epub 2012 Aug 2.
7
Polymorphisms of the Serotonin Transporter Gene and G-Protein β3 Subunit Gene in Korean Children with Irritable Bowel Syndrome and Functional Dyspepsia.韩国肠易激综合征和功能性消化不良儿童的 5-羟色胺转运体基因和 G 蛋白β3 亚单位基因多态性。
Gut Liver. 2012 Apr;6(2):223-8. doi: 10.5009/gnl.2012.6.2.223. Epub 2012 Apr 17.
8
Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls.肠易激综合征患者和健康对照者的 5-羟色胺转运体基因(SLC6A4)多态性。
J Gastrointestin Liver Dis. 2012 Mar;21(1):31-8.
9
Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.肠易激综合征患者结肠黏膜中 5-羟色胺转运体基因启动子区多态性与 5-羟色胺转运体表达
Neurogastroenterol Motil. 2012 Jun;24(6):560-5, e254-5. doi: 10.1111/j.1365-2982.2012.01902.x. Epub 2012 Mar 21.
10
Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.枸橼酸莫沙必利对肠易激综合征患者直肠乙状结肠感觉运动功能的影响。
Neurogastroenterol Motil. 2011 Aug;23(8):754-e332. doi: 10.1111/j.1365-2982.2011.01732.x. Epub 2011 May 25.